PMID- 34433743 OWN - NLM STAT- MEDLINE DCOM- 20220328 LR - 20220328 IS - 1882-0654 (Electronic) IS - 0009-918X (Linking) VI - 61 IP - 9 DP - 2021 Sep 28 TI - [Eosinophilic granulomatosis with polyangiitis presenting with Guillain-Barre syndrome-like acute course. A case report]. PG - 624-629 LID - 10.5692/clinicalneurol.cn-001601 [doi] AB - A 57-years-old man with a history of bronchial asthma and pansinusitis developed acute progressive muscle weakness and sensory disturbance of the distal limbs after upper respiratory infection. On day 15 after onset of sensory disturbance and muscle weakness, the patient admitted to our hospital. A neurological examination revealed asymmetry weakness of both proximal and distal muscles, "glove and stocking type" hypoesthesia, and paresthesia without obvious pain. Blood tests and a nerve conduction study demonstrated eosinophilia and elevation of MPO-ANCA, axonal multiple mononeuropathy, respectively. The cerebrospinal fluid was normal. Eosinophilic granulomatosis with polyangiitis (EGPA) or Guillain-Barre syndrome (GBS) were suspected. So intravenous immunoglobulin therapy (IVIg) and high dose methylprednisolone pulse therapy (HDMP) followed by oral prednisolone were started. However, neurological symptoms did not improve. Sural nerve biopsy on day 31 revealed varying myelinating fiber loss at every nerve bundle and perivascular lymphocytic infiltration. The results did not fulfill the pathologic criteria for EGPA, but supported the changes of vasculitis. Cyclophosphamide (CPA) pulse therapy was administered for the additional therapy. Neurological symptoms did not improve and worsened again after decreasing oral prednisolone; therefore, combined therapy with IVIg, HDMP, and CPA was administered. Neurological symptoms then diminished gradually and the MPO-ANCA level and number of eosinophils normalized. This case suggests the importance of early nerve biopsy to obtain pathological findings supportive of EGPA diagnosis to allow introduction of aggressive immunosuppressive therapy such as CPA in a case with acute progressive motor-sensory neuropathy due to EGPA mimicking GBS. FAU - Ueda, Ryota AU - Ueda R AD - Department of Neurology and Stroke Treatment, Kyoto Daiichi Red Cross Hospital. FAU - Imai, Keisuke AU - Imai K AD - Department of Neurology and Stroke Treatment, Kyoto Daiichi Red Cross Hospital. FAU - Yamamoto, Atsushi AU - Yamamoto A AD - Department of Neurology and Stroke Treatment, Kyoto Daiichi Red Cross Hospital. FAU - Ioku, Tetsuya AU - Ioku T AD - Department of Neurology and Stroke Treatment, Kyoto Daiichi Red Cross Hospital. FAU - Kadoya, Masatoshi AU - Kadoya M AD - Department of Rheumatology, Kyoto Daiichi Red Cross Hospital. FAU - Hamanaka, Masashi AU - Hamanaka M AD - Department of Neurology, Kyoto Daini Red Cross Hospital. LA - jpn PT - Case Reports PT - Journal Article DEP - 20210826 PL - Japan TA - Rinsho Shinkeigaku JT - Rinsho shinkeigaku = Clinical neurology JID - 0417466 RN - 0 (Antibodies, Antineutrophil Cytoplasmic) RN - 0 (Immunoglobulins, Intravenous) RN - 9PHQ9Y1OLM (Prednisolone) SB - IM MH - Antibodies, Antineutrophil Cytoplasmic MH - *Churg-Strauss Syndrome MH - *Granulomatosis with Polyangiitis MH - *Guillain-Barre Syndrome/diagnosis MH - Humans MH - Immunoglobulins, Intravenous MH - Middle Aged MH - Muscle Weakness MH - Prednisolone OTO - NOTNLM OT - Guillain-Barre syndrome OT - cyclophosphamide pulse therapy OT - eosinophilic granulomatosis with polyangiitis OT - intravenous immunoglobulin therapy OT - nerve biopsy EDAT- 2021/08/27 06:00 MHDA- 2022/03/29 06:00 CRDT- 2021/08/26 05:38 PHST- 2021/08/27 06:00 [pubmed] PHST- 2022/03/29 06:00 [medline] PHST- 2021/08/26 05:38 [entrez] AID - 10.5692/clinicalneurol.cn-001601 [doi] PST - ppublish SO - Rinsho Shinkeigaku. 2021 Sep 28;61(9):624-629. doi: 10.5692/clinicalneurol.cn-001601. Epub 2021 Aug 26.